Session Information
Date: Wednesday, June 7, 2017
Session Title: Cognitive Disorders
Session Time: 1:15pm-2:45pm
Location: Exhibit Hall C
Objective: Investigating the effect of chronic administration of the dopamine D2/3 agonist ropinirole on a cued model of gambling behaviour in rats.
Background: Dopamine D2/3 agonists are successfully used to treat the motor symptoms of Parkinson’s Disease (PD), either as adjunct to L-DOPA, or as stand alone treatments. However, these dopamine agonists may lead to impulse control disorders (ICD) including pathological gambling in some patients. We have previously observed that chronic ropinirole increased choice of uncertain options on the rat Betting Task (rBT), a paradigm that captures aspects of risk aversion. In contrast, ropinirole transiently increased premature responses, a measure of motor impulsivity observed in models of addiction, without influencing choice on the rat Gambling Task (rGT). The rGT is a rodent analogue of the Iowa Gambling Task used clinically to assess decision making under risk in which rats choose between four options, each associated with differing probabilities of reward and punishment. Repeated exposure to cues that predict reward with maximal uncertainty may sensitize the dopamine system and predispose subjects to addiction disorders such as gambling. Although win-associated stimuli are salient in casinos, they are not featured on the original version of the rGT, which may explain the lack of effect of ropinirole on choice in the uncued task. We therefore tested if chronic ropinirole would increase choice of risky options on a cued version of the rGT. Win-associated cues were previously shown to increase rats’ preference for the riskier options on this task.
Methods: Subjects were 40 male rats performing the cued rGT and implanted with an osmotic pump delivering either ropinirole (5mg/kg/day) or saline for 28 days.
Results: Ropinirole led to a larger and more long-lasting increase in premature responses on the cued rGT with no effect on choice, consistent with results on the original rGT.
Conclusions: Together with other data, our results suggest that the rGT and the rBT may model decision-making deficits linked to different disorders. Chronic ropinirole increases preference for uncertainty on the rBT, potentially akin to problem gambling behaviour, whereas this drug increases impulsivity on the rGT, which may represent an endophenotype for impulse control disorders or drug addiction.
To cite this abstract in AMA style:
M. Tremblay, M. Barrus, P. Cocker, S. Kaur, C. Winstanley. Adding cues to a rat gambling task potentiates the increase in premature responding in response to chronic D2/3 agonist ropinirole without mitigating preference for risk [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/adding-cues-to-a-rat-gambling-task-potentiates-the-increase-in-premature-responding-in-response-to-chronic-d23-agonist-ropinirole-without-mitigating-preference-for-risk/. Accessed November 22, 2024.« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/adding-cues-to-a-rat-gambling-task-potentiates-the-increase-in-premature-responding-in-response-to-chronic-d23-agonist-ropinirole-without-mitigating-preference-for-risk/